MK-0916 is a HSD1 inhibitor. MK-0916 produces mechanism-based activation of the hypothalamic-pituitary-adrenal axis. MK-0916 can be used in the research of type 2 diabetes and metabolic syndromes[1].
Molecular Weight:
331.81
CAS Number:
[633317-53-0]
Formula:
C18H19ClFN3
Target:
11beta-HSD
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
